Clinical Trials Directory

Trials / Completed

CompletedNCT01251393

Cocaine/Crack and Reduction of Compulsion With Biperiden

Cocaine/Crack Dependence: A Study of the Possible Reduction of Compulsion Under the Use of Biperiden

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
111 (actual)
Sponsor
Federal University of São Paulo · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Considering the effects of the cholinergic system on the drug reward and self-administration mechanisms, acetylcholine (Ach) may play an important role on cocaine dependence process. Then the present study aims to evaluate biperiden efficacy (a cholinergic antagonist) in attenuate compulsion, one o the main symptoms of the drug dependence.

Detailed description

Cocaine consumption affects around 13.4 mi people or 0.3% of the world population between 15 and 64 years old. The drug dependence has been described by many authors as a dysfunction of the brain reward system. Considering the effects of the cholinergic system on the drug reward and self-administration mechanisms, acetylcholine (Ach) may play an important role on cocaine dependence process. Then the present study aims to evaluate biperiden efficacy (a cholinergic antagonist) in attenuate compulsion, one o the main symptoms of the drug dependence. To accomplish this purpose 60 cocaine or crack male users between 18 and 50 years old will be study. This is a double-blind controlled and randomized placebo study. All the patients will be treated with brief intervention therapy (BIT), and half of them will receive biperiden (6mg/day) while the other half will receive placebo. The treatment efficacy will be evaluated through the comparison between the values obtained on the following measures before and after the treatment: Craving scale of Minnesota and Cocaine/crack consumption questionnaire, and the presence of the cocaine metabolite (benzoylecgonine) on urine.

Conditions

Interventions

TypeNameDescription
DRUGBiperidenThirty volunteers will take three pills of Biperiden (6mg/day) during two months.
DRUGPlaceboThirty volunteers will take three pills of Placebo (6mg/day) during two months.

Timeline

Start date
2011-05-01
Primary completion
2011-12-01
Completion
2012-11-01
First posted
2010-12-01
Last updated
2020-10-14
Results posted
2020-02-28

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01251393. Inclusion in this directory is not an endorsement.